BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/21/2026 3:32:18 AM | Browse: 3 | Download: 0
 |
Received |
|
2026-02-27 05:43 |
|
Peer-Review Started |
|
2026-02-27 05:48 |
|
First Decision by Editorial Office Director |
|
2026-03-09 09:12 |
|
Return for Revision |
|
2026-03-09 09:12 |
|
Revised |
|
2026-03-10 14:49 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2026-05-20 02:41 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2026-05-20 07:47 |
|
Articles in Press |
|
2026-05-20 07:47 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2026-07-09 09:43 |
|
Publish the Manuscript Online |
|
2026-08-21 03:32 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Correspondence |
| Article Title |
Letter to the Editor: Helicobacter pylori eradication in aspirin users - gastroprotection established, cardiovascular implications to be clarified
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Yavuz Özden |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Yavuz Özden, MD, Department of Gastroenterology, Kayseri City Hospital, University of Health Sciences, Şeker District, Muhsin Yazıcıoğlu Boulevard No. 77 Kocasinan, Kayseri 38080, Türkiye. yavuzozden@gmail.com |
| Key Words |
Helicobacter pylori; Aspirin; Peptic ulcer bleeding; Cardiovascular risk; Eradication therapy; Gastroprotection |
| Core Tip |
Helicobacter pylori eradication in chronic aspirin users appears to provide meaningful gastrointestinal protection and may reduce peptic ulcer bleeding risk. However, the reported cardiovascular benefit should be interpreted cautiously because of short follow-up, composite endpoint selection, possible residual confounding, and modest eradication success. Future studies should focus on optimized eradication strategies and hard cardiovascular outcomes. |
| Publish Date |
2026-08-21 03:32 |
| Citation |
Özden Y. Letter to the Editor: Helicobacter pylori eradication in aspirin users - gastroprotection established, cardiovascular implications to be clarified. World J Gastroenterol 2026; 32(35): 120142
|
| URL |
https://www.wjgnet.com/1007-9327/full/v32/i35/120142.htm |
| DOI |
https://doi.org/10.3748/wjg.120142 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
